Status:
COMPLETED
Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs
Lead Sponsor:
University of Westminster
Collaborating Sponsors:
Gencor Pacific Group
Conditions:
Iron Deficiency (Without Anemia)
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
INTRODUCTION: Iron is a vital nutrient for many physiological processes including DNA production, oxygen transport and neuronal processes. However, several factors limit iron absorption including: lim...
Detailed Description
Intervention study with five parallel treatment groups in a randomised, double-blind, placebo-controlled design. Study population: Healthy Participants (Male or Female) will receive daily supplements...
Eligibility Criteria
Inclusion
- Males \& Females (18-40 years of age)
- Healthy subjects
Exclusion
- \<18 years or \>40 years
- Dieters
- Consumption of \>21 serving of alcohol/week
- Any allergies/health issues related to items being ingested
- Any serious illnesses or those on medication
- Any pregnant or lactating women
- Any women who are trying to conceive
- Any women taking contraceptive medication
- Any gastrointestinal disorders
- Any chronic menstrual disorders
- Any subjects who have undergone the menopause or undergoing the perimenopause transition
- Any eating disorders
- Any depression/mental disorders
- Any abnormal blood pressure levels
- Those with deficient/excess/abnormal iron levels according to United Kingdom (UK) guidelines \&/or haemochromatosis
Key Trial Info
Start Date :
July 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2020
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT04465851
Start Date
July 18 2018
End Date
January 31 2020
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Westminster
London, United Kingdom, W1W 6UW